Dr. Jacob “Jake” VanLandingham is a neuroscientist and entrepreneur known for his work in pharmaceutical development, particularly in the area of concussion treatment. He earned his undergraduate degree from Florida A&M University in 1997 and a doctorate from Florida State University in 2004. Following his academic pursuits, Dr. VanLandingham served as an assistant professor and researcher at Florida State University’s College of Medicine, where he focused on neuroscience and movement disorders.